NCT04203173Completed
Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1
Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes - FINANCE-DM
Source: ClinicalTrials.gov · Last updated 24 Jul 2026
Brief summary (registry, in English)
The objective of this protocol is to answer the questions: 1) Are financial incentives layered upon nurse education and home telemonitoring superior to nurse education and home telemonitoring alone in improving metabolic control long term? 2) Are the effects of financial incentives on metabolic control sustained once the incentives are withdrawn? and 3) Are financial incentives efficacious within and consistent across racial/ethnic groups? This study provides a unique opportunity to address these gaps in the literature. Investigators propose a randomized controlled trial to test the efficacy of a Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM) intervention comprised of: 1) nurse education, 2) home telemonitoring, and 3) structured financial incentives; compared to an active control group (nurse education and home telemonitoring alone). The study also will evaluate whether intervention effects are sustained 6 months after the financial incentives are withdrawn (i.e. 18 months post randomization); and whether the intervention is differentially efficacious across racial/ethnic groups.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 450 (actual)
- First submitted
- 26 Nov 2019
- Start date
- 1 Dec 2019
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- State University of New York at Buffalo
- Diseases
- Type 1 diabetes, Type 2 diabetes
- NCT number
- NCT04203173
What you commit to
- Study type: Interventional
- Participants enrolled: 450
- From 1 Dec 2019 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Alcohol or drug abuse/dependency;
Other illness
- Mental confusion on interview suggesting significant dementia;
- Participation in other diabetes clinical trials;
- Active psychosis or acute mental disorder; and
Other
- Life expectancy \<18 months.
Who the study is looking for
- Age \>=21 years;
- Clinical diagnosis of T2DM and HbA1c \>=8% at the screening visit;
- Self-identified as White, AA or HA;
- Subject must be willing to use the FORA monitoring system for 12 months;
- Subjects must have access to a landline, Ethernet or cellphone for FORA data uploads for the study period; and 6) Ability to communicate in English.
Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| State University of New York at Buffalo Coordinator of this site? Confirm its status | Buffalo | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.